fluorodeoxyglucose f18 has been researched along with Skin Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Suga, K | 1 |
| Kobayashi, M | 1 |
| Green, C; Lyburn, ID; Nawwar, AA; Searle, J | 1 |
| Beaudin, M; Lambert, R; Mitchell, G; Patey, N; Turpin, S | 1 |
| Besson, FL; Bompard, F; Chekroun, M; de Menthon, M; Durand, E; Gomez, L; Gottlieb, J; Goujard, C; Grimon, G; Saleh, NS | 1 |
| Chae, SY; Chang, SE; Jin, S; Lee, SW; Ryu, JS; Suh, C | 1 |
| Bal, C; Gupta, RK; Kumar, K; Kumar, R; Singh, H | 1 |
| Deng, S; Sang, S; Sui, X; Zhang, B; Zhang, W | 1 |
| Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
| Hsiao, CH; Huang, JY; Lu, CC; Tzen, KY | 1 |
| Berenji, GR; Li, Y | 1 |
| Cassar-Pullicino, VN; Depasquale, R; Kumar, N; Lalam, RK; Singh, J; Tins, BJ; Tyrrell, PN | 1 |
| Abe, K; Baba, S; Furue, M; Honda, H; Isoda, T; Kiryu, H; Maruoka, Y; Sasaki, M; Shinmura, A; Yasukawa, F | 1 |
| Han, YM; Hwang, DH; Hwang, HS; Kang, IW; Ko, Y; Lee, ES; Lee, GK | 1 |
| Alavi, A; Fried, RG; Junkins-Hopkins, JM; Rook, AH; Saidman, BH; Schulman, N; Shapiro, M; Vittorio, CC; Yun, M | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Skin Diseases
| Article | Year |
|---|---|
F-18-FDG PET/CT findings of paraneoplastic dermatoses.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin Diseases; Tomography, X-Ray Computed | 2022 |
SAPHO: What radiologists should know.
Topics: Acquired Hyperostosis Syndrome; Adult; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Diseases; Spinal Diseases; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
13 other study(ies) available for fluorodeoxyglucose f18 and Skin Diseases
| Article | Year |
|---|---|
Asymptomatic tiny subcutaneous eruptions in a patient with sarcoid neuropathy: the effectiveness of fluorine-18 fluorodeoxyglucose positron emission tomography for targeting safe biopsy sites.
Topics: Asymptomatic Diseases; Biopsy; Central Nervous System Diseases; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Skin Diseases; Subcutaneous Tissue; Whole Body Imaging | 2019 |
Infection Control of COVID-19: Surgical Mask-Related Facial Cutaneous Artifact on FDG PET/CT.
Topics: Artifacts; COVID-19; Fluorodeoxyglucose F18; Humans; Infection Control; Lymphoma; Male; Masks; Middle Aged; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Skin Diseases | 2021 |
H Syndrome: A Rare Genodermatosis Imaged With 18F-FDG PET/CT.
Topics: Child; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Rare Diseases; Skin Diseases | 2018 |
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Skin Diseases | 2019 |
A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Brain Diseases; Fluorodeoxyglucose F18; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Skin Diseases; Young Adult | 2014 |
Erlotinib-induced cutaneous toxicity: findings on 18F-FDG PET/CT imaging.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Skin Diseases; Tomography, X-Ray Computed | 2015 |
Elevated 18F-FDG Uptake in Skeletal Muscles Rather Than Cutaneous Foci in a Patient With Sweet's Syndrome.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Skin Diseases; Sweet Syndrome | 2016 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
FDG PET/CT findings in purely cutaneous Rosai-Dorfman disease.
Topics: Adult; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Male; Positron-Emission Tomography; Skin Diseases; Tomography, X-Ray Computed | 2011 |
Cutaneous sarcoidosis evaluated by FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis; Skin Diseases; Tomography, X-Ray Computed | 2011 |
FDG PET/CT findings in acquired perforating dermatosis.
Topics: Adult; Diabetes Mellitus; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Renal Dialysis; Skin Diseases; Tomography, X-Ray Computed | 2012 |
Role of 18F-FDG PET/CT in the diagnosis of clinically suspected Marjolin ulcer.
Topics: Adult; Aged; Burns; Carcinoma, Squamous Cell; Chronic Disease; Contracture; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Diseases; Skin Neoplasms; Skin Ulcer; Tomography, X-Ray Computed | 2012 |
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Neoplasm Staging; Radiopharmaceuticals; Skin Diseases; Tomography, Emission-Computed; Treatment Outcome | 2002 |